biomatrix8k_1-510.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K/A
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported)
January
5, 2010
------------------------
BIO-MATRIX
SCIENTIFIC GROUP, INC.
------------------------------------------------------
(Exact
Name of Registrant as Specified in Its Charter)
DELAWARE
----------------------------------------------
(State or
Other Jurisdiction of Incorporation)
0-32201 33-0824714
------------------------
---------------------------------
(Commission File Number) (IRS
Employer Identification No.)
8885
Rehco Road, San Diego, California 92121
-------------------------------------------------------------------------
(Address
of Principal Executive Offices) (Zip
Code)
619 702
1404
----------------------------------------------------
(Registrant's
Telephone Number, Including Area Code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[
] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
[
] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
The
Registrant hereby amends its Current Report on Form 8-K/A dated December 31,
2009 to file as an exhibit the letter requested from its former auditor (a copy
of which was received by the Registrant on January 5, 2010) with respect to the
statements made in the 8-K/A.
ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS
The
following exhibit is filed with this report.
No.
Description
16.1
Letter,
dated January 5, 2010 of Seale and Beers, CPAs
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
BIO-MATRIX
SCIENTIFIC GROUP, INC.
|
By: /s/ David Koos
David
Koos
Chief
Executive Officer
Dated:
January 8, 2010
|